Participate in a Study
What We Do
Direct-to-Patient Site
Patient Recruitment
Research-Grade Nursing
Case Studies
Who We Are
About Us
Investigators
News
Resources
Careers
Events
Contact Us
hello world!
Webinars
Webinar
10 Things You Didn't Know About a Virtual Site
Virtual sites present a viable solution for sponsors and researchers by providing a patient-friendly option […]
Webinar
The Metasite™ in Action: Unleash the Power of a Virtual Site
Emerging biopharma and top pharma companies alike are looking to virtual sites to expand patient access, deliver…
Webinar
Navigating the FDA's Draft Guidance on DCTs—A Roadmap for Trial Sponsors
In May of 2023, the FDA released a new Draft Guidance on decentralized clinical trials […]
Webinar
Science 37 Launches Infectious Disease Prevention Study in Just 12 Weeks
A biotech sponsor contracted Science 37 to help enroll patients in a global Phase 2/3 registrational study with 95+ sites in 30 countries. Acting as a virtual site, Science 37 worked alongside traditional sites to reach a broader patient population and accelerate time-to-market.
Webinar
The Clinical Trial Shift: Sites that Follow the Patient
In this video-on-demand, find out why a patient-centered approach requires both a shift—a mind shift—and a pragmatic, coordinated approach to seeing it through. Science 37 CEO, David Coman, and VP of Internal Medicine, Dr. Debra Weinstein, join a group of leaders from Bayer, Janssen, and Novartis, to discuss what the ideal patient model really is—and how to deliver this patient-first approach.
Webinar
Science 37 Accelerates Oncology Clinical Trial Timeline by 3 Years
A biopharma company was investigating how its diagnostic screening technology—a one-time blood sample—performed against the gold-standard cancer screening procedure. The protocol required 25,000 average-risk patients between the ages of 45 and 85 to enroll. The sponsor also looked to include a diverse and representative population in the trial. See how the Science 37 Metasite™ enrolled nearly 50% of the entire study with 24.2% minority representation, enabling recruitment and access across 49 states. This accelerated approach resulted in a more than 3-year reduction of the clinical trial timeline. Submit the form to watch the case study video.
Webinar
Science 37 Enables Real-Time Data Collection in Phase 4 Study
This top pharma sponsor approached Science 37 to conduct a Phase 4 clinical trial for patients with diabetes in Demark, requiring continuous data collection via biosensors for 12 weeks. The Science 37 Metasite™ was used to operationalize the end-to-end clinical trial, from patient recruitment and eConsent to the collection and aggregation of data. See how Science 37’s innovative trial design supported patients remotely and provided the sponsor with real-time access to sensor data.
Webinar
Science 37 Delivers 96% Patient Retention in Fully Remote Study
Science 37 conducted a fully decentralized trial for patients with systemic lupus erythematosus and sjogren's syndrome using a single virtual site model. The sponsor aimed to enhance data insight, enrollment speed, patient retention, and real-world representation, addressing the historical underrepresentation of minority groups in lupus studies. See how the Science Metasite™ delivered the trial directly to patients in their homes with remote study conduct. This approach resulted in a 96% patient retention rate and diverse representation among study participants.
Webinar
Science 37 Delivers Diverse Patient Enrollment in Respiratory Clinical Trial
In a study for a respiratory syncytial virus (RSV) vaccine, Science 37 was contracted to deliver end-to-end remote clinical trial management and workflow orchestration. The biotech sponsor needed improved recruitment, enrollment, retention, and diversity. See how the Science 37 Metasite™ met more than 85% black/hispanic enrollment by eliminating in-person monthly visits and enabling patients to participate from home.
Webinar
Science 37 Accelerates Enrollment for Dermatology Clinical Trial
A biopharma company was conducting a Phase 2 randomized controlled trial in the United States for patients aged 18 and older with mild-to-moderate acne. The sponsor faced challenges with recruiting a diverse and representative patient population as well as study start-up time. See how the Science 37 MetasiteTM enrolled 372 individuals in 7 months, providing 82% patient retention and diversity to meet skin tone requirements by offering at-home participation and flexible treatment options.
Webinar
Science 37 Launches Infectious Disease Prevention Study in Just 12 Weeks
A biotech sponsor contracted Science 37 to help enroll patients in a global Phase 2/3 registrational study with 95+ sites in 30 countries. Acting as a virtual site, Science 37 worked alongside traditional sites to reach a broader patient population and accelerate time-to-market. See how the Science 37 MetasiteTM was the top enrolling site in the study, achieving more than 90% patient retention and a start-up time of 12 weeks across all 50 U.S. states.
Webinar
The Metasite™ in Action: How to Operationalize a Virtual Site for Infectious Disease
In this 30-minute video-on-demand, a panel of experts discuss how to safely, compliantly, and efficiently operationalize a virtual site. They also cover how virtual sites (such as the Science 37 Metasite™), help address many challenges in infectious disease research and explore case studies that show how sponsors and CROs leverage virtual trials to improve access, equity, and ultimately accelerate recruitment and enrollment.
Webinar
The Metasite™ in Action: How to Operationalize a Virtual Site for Dermatology
In this video-on-demand, join a panel of experts and learn first-hand how to safely, compliantly, and efficiently operationalize a virtual site. Discover how virtual sites (such as the Science 37 Metasite™), help address many challenges in dermatologic research. Explore case studies that show how sponsors and CROs leverage decentralized clinical trials to improve access, equity, and ultimately accelerate recruitment and enrollment.
Webinar
Navigating the FDA's Draft Guidance on DCTs—A Roadmap for Trial Sponsors
In May of 2023, the FDA released a new Draft Guidance on decentralized clinical trials […]
Webinar
The Clinical Trial Shift: Sites that Follow the Patient
In this video-on-demand, find out why a patient-centered approach requires both a shift—a mind shift—and a pragmatic, coordinated approach to seeing it through. Science 37 CEO, David Coman, and VP of Internal Medicine, Dr. Debra Weinstein, join a group of leaders from Bayer, Janssen, and Novartis, to discuss what the ideal patient model really is—and how to deliver this patient-first approach.
Webinar
Disrupting the Clinical Trial: When to Decentralize?
Learn more about agile technologies and industry standards that are needed to drive clinical trial innovation, as we move towards universal adoption of decentralization.
Webinar
Virtual Sites - Are They the Future of RWE?
The adoption of virtual sites, that are powered by decentralized clinical trial tools, has increased exponentially in recent years. In this video-on-demand, industry leaders discuss how virtual sites can be implemented to improve real-world data access and long-term follow-up, as well as elaborate on the value virtual sites deliver to patients, sponsors, and CROs alike. Learn how virtual site elements are incorporated today, and how the landscape will change in the years to come.
Webinar
Let's Plan, Do, Check, and Act: Leading Diversity in Clinical Trials Through Effective Metrics
The Equity intention of the FDA is clear, the pharmaceutical industry must provide a Diversity Action Plan for all submissions—making trials more inclusive. This must be done through an evidence-based approach, providing a rationale for efficacy and safety to underrepresented populations, describing how the trials address inclusion, establishing goals for enrollment, operational tactics for enrollment and retention, and continuous monitoring to improve plans.
Webinar
Decentralization in Action: What Oncology Trials Look Like Now
What current clinical research looks like with oncology trials
Webinar
What Clinical Trial Participants Want — And How Sponsors can Deliver
Science 37 carefully examines all clinical trial options and elements needed for research — helping sponsors craft the best model to deliver clinical trial value. From cost and time savings to improved diversity, risk reduction and more, the featured speakers will evaluate the importance of decentralized clinical trials (DCTs).
Webinar
Webinar—How Decentralized Clinical Trials are Impacting Research
Learn more about agile technologies and industry standards that are needed to drive clinical trial innovation, as we move towards universal adoption of decentralization.
Webinar
Increasing Participation of Women in Oncology Clinical Trials
There are low numbers of women in oncology clinical trials. Why aren’t more women represented?
Webinar
Oncology Clinical Trials: How Hybrid Approaches are Changing The Clinical Landscape
Is your oncology clinical trial prepared for the next generation of trial methodologies?
Webinar
New Data on the Future of CNS Clinical Trials
Which decentralized components have been, and will be, most important in CNS clinical trials? What are the perceived benefits and challenges of using DCT approaches to execute CNS trials? Find out at our upcoming webinar event
Webinar
The Agile Trial: A New Clinical Leadership
Interested in reading more about how agile and decentralized approaches actually offer sponsors more centralized command and […]
Privacy & Consent
Privacy Policy
Cookies Notice & Consent
Mobile Privacy Policy
Terms & Conditions
SMS Texting Terms & Conditions
Consumer Health Privacy Notice
Privacy Choices
What We Do
Direct-to-Patient Site
Patient Recruitment
Research-Grade Nursing
Case Studies
Who We Are
About Us
Investigators
News
Resources
Careers
Events
Contact Us
Participate in a Study
© 2025 Science 37 | All Rights Reserved
linkedin
